The amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: De-regulation of mitochondrial genes may be involved

Journal of Human Genetics

Volumn 57, Issue 4, 2012, Pages 269-276

  Guardado Estrada, Mariano ^a   Medina Martínez, Ingrid ^a   Juárez Torres, Eligia ^a   Roman Bassaure, Edgar ^b   MacÍas, Luis ^a   Alfaro, Ana ^a   Alcántara Vázquez, Avissai ^b   Alonso, Patricia ^b   Gomez, Guillermo ^b   Cruz Talonia, Fernando ^b   Serna, Luis ^b   Muñoz Cortez, Sergio ^c   Borges Ibañez, Manuel ^c   Espinosa, Ana ^a   Kofman, Susana ^a   Berumen, Jaime ^a,d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amerindian haplogroups; cervical cancer; HPV; MT tRNA; mtDNA; polymorphism

Indexed keywords

ASPARTIC ACID TRANSFER RNA; LYSINE TRANSFER RNA; MITOCHONDRIAL DNA;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC RISK; HAPLOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MITOCHONDRIAL GENE; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; SAMPLE SIZE; TUMOR BIOPSY; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; ALLELES; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENES, MITOCHONDRIAL; HAPLOTYPES; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; INDIANS, NORTH AMERICAN; MIDDLE AGED; MITOCHONDRIA; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84860288329     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2012.17     Document Type: Article

References (52)

1. Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518-527 (2003). (Pubitemid 36159887)
2. Schlecht, N. F., Platt, R. W., Duarte-Franco, E., Costa, M. C., Sobrinho, J. P., Prado, J. C. M. et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 95, 1336-1343 (2003). (Pubitemid 37160867)
3. Wang, S. S. & Hildesheim, A. Chapter 5: Viral and host factors in human papillomavirus persistence and progression. JNCI Monogr. 2003, 35-40 (2003).
4. Magnusson, P. K. E., Lichtenstein, P. & Gyllensten, U. B. Heritability of cervical tumours. Int. J. Cancer 88, 698-701 (2000).
5. Hemminki, K. & Chen, B. Familial risks for cervical tumors in full and half siblings: Etiologic apportioning. Cancer Epidemiol. Biomarkers Prev. 15, 1413-1414 (2006). (Pubitemid 44125303)
6. Zelmanowicz Ade, M., Schiffman, M., Herrero, R., Goldstein, A. M., Sherman, M. E., Burk, R. D. et al. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: Results from two studies conducted in Costa Rica and the United States. Int. J. Cancer 116, 599-605 (2005). (Pubitemid 41099197)
7. Couto, E. & Hemminki, K. Heritable and environmental components in cervical tumors. Int. J. Cancer 119, 2699-2701 (2006). (Pubitemid 44691327)
8. Engelmark, M., Beskow, A., Magnusson, J., Erlich, H. & Gyllensten, U. Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum. Mol. Genet. 13, 1951-1958 (2004). (Pubitemid 39214342)
9. de Araujo Souza, P. S., Sichero, L. & Maciag, P. C. HPV variants and HLA polymorphisms: The role of variability on the risk of cervical cancer. Fut. Oncol. 5, 359-370 (2009).
10. Wang, S. S., Gonzalez, P., Yu, K., Porras, C., Li, Q., Safaeian, M. et al. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 5, e8667 (2010).
11. Thakur, N., Hussain, S., Kohaar, I., Tabassum, R., Nasare, V., Tiwari, P. et al. Genetic variant of CCND1: Association with HPV-mediated cervical cancer in Indian population. Biomarkers 14, 219-225 (2009).
12. Ivansson, E. L., Gustavsson, I. M., Magnusson, J. J., Steiner, L. L., Magnusson, P. K. E., Erlich, H. A. et al. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int. J. Cancer 121, 2451-2457 (2007). (Pubitemid 350022414)
13. Fletcher, O. & Houlston, R. S. Architecture of inherited susceptibility to common cancer. Nat. Rev. Cancer 10, 353-361 (2010).
14. Yang, Y.-C., Chang, T.-Y., Lee, Y.-J., Su, T.-H., Dang, C.-W., Wu, C.-C. et al. HLADRB1 alleles and cervical squamous cell carcinoma: Experimental study and metaanalysis. Hum. Immunol. 67, 331-340 (2006). (Pubitemid 43729364)
15. Fernandez-Silva, P., Enriquez, J. A. & Montoya, J. Replication and transcription of mammalian mitochondrial DNA. Exp. Physiol. 88, 41-56 (2003). (Pubitemid 36150058)
16. Bayona-Bafaluy, M. P., López-Gallardo, E., Montoya, J. & Ruiz-Pesini, E. Maternally inherited susceptibility to cancer. Biochim. Biophys. Acta 1807, 643-649 (2011).
17. Brandon, M., Baldi, P. & Wallace, D. C. Mitochondrial mutations in cancer. Oncogene 25, 4647-4662 (2006). (Pubitemid 44187615)
18. Singh, K. K. & Kulawiec, M. Mitochondrial DNA polymorphism and risk of cancer. Methods Mol. Biol. 471, 291-303 (2009).
19. Booker, L. M., Habermacher, G. M., Jessie, B. C., Sun, Q. C., Baumann, A. K., Amin, M. et al. North American white mitochondrial haplogroups in prostate and renal cancer. J. Urol. 175, 468-473 (2006).
20. Fang, H., Shen, L., Chen, T., He, J., Ding, Z., Wei, J. et al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 10, 421 (2010).
21. Maca-Meyer, N., Gonzalez, A., Larruga, J., Flores, C. & Cabrera, V. Major genomic mitochondrial lineages delineate early human expansions. BMC Genet. 2, 13 (2001).
22. Pello, R., Martín, M. A., Carelli, V., Nijtmans, L. G., Achilli, A., Pala, M. et al. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum. Mol. Genet. 17, 4001-4011 (2008). (Pubitemid 352762860)
23. Guardado-Estrada, M., Juarez-Torres, E., Medina-Martinez, I., Wegier, A., Macias, A., Gomez, G. et al. A great diversity of Amerindian mitochondrial DNA ancestry is present in the Mexican mestizo population. J. Hum. Genet. 54, 695-705 (2009).
24. Lazcano-Ponce, E., Herrero, R., Munoz, N., Cruz, A., Shah, K. V., Alonso, P. et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer 91, 412-420 (2001). (Pubitemid 32049638)
25. Shepherd, J. H. Revised FIGO staging for gynaecological cancer. BJOG 96, 889-892 (1989).
26. Manos, M. M., Ting, Y., Wright, D. K., Lewis, A. J., Broker, T. R. & Wolinski, S. M. in The Use of Polymerase Chain Reaction Amplification for the Detection of Genital Human Papillomaviruses (eds Furth, M. & Greaves, M. F.) 209-214 (Cold Spring Harbor, New York, 1989).
27. van den Brule, A. J., Meijer, C. J., Bakels, V., Kenemans, P. & Walboomers, J. M. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J. Clin. Microbiol. 28, 2739-2743 (1990).
28. Yoshikawa, H., Kawana, T., Kitagawa, K., Mizuno, M., Yoshikura, H. & Iwamoto, A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Cancer Sci. 82, 524-531 (1991).
29. Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J. et al. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 38, W695-W699 (2010).
30. Mueller, E. E., Eder, W., Mayr, J. A., Paulweber, B., Sperl, W., Horninger, W. et al. Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European Caucasians. PLoS One 4, e6370 (2009).
31. Klemba, A., Kowalewska, M., Kukwa, W., Tonska, K., Szybinska, A., Mossakowska, M. et al. Mitochondrial genotype in vulvar carcinoma-cuckoo in the nest. J. Biomed. Sci. 17, 73 (2010).
32. Czarnecka, A., Klemba, A., Semczuk, A., Plak, K., Marzec, B., Krawczyk, T. et al. Common mitochondrial polymorphisms as risk factor for endometrial cancer. Int. Arch. Med. 2, 33 (2009).
33. Liu, V. W. S., Wang, Y., Yang, H.-J., Tsang, P. C. K., Ng, T.-Y., Wong, L.-C. et al. Mitochondrial DNA variant 16189T4C is associated with susceptibility to endometrial cancer. Hum. Mutat. 22, 173-174 (2003). (Pubitemid 36950816)
34. Wang, Y. U. E., Liu, V. W. S., Ngan, H. Y. S. & Nagley, P. Frequent occurrence of mitochondrial microsatellite instability in the D-loop region of human cancers. Ann. N Y Acad. Sci. 1042, 123-129 (2005). (Pubitemid 40967629)
35. Barbosa, A., Antonio, L., Dalmo, d.S, Valdir, A. & Luiz, B. Mitochondrial DNA control region polymorphism in the population of Alagoas State, North-Eastern Brazil. J. Forensic Sci. 53, 142-146 (2008). (Pubitemid 351239232)
36. Salas, A., Acosta, V., lvarez-Iglesias, M., Cerezo, C., Phillips, M. V. & Carracedo, L. The mtDNA ancestry of admixed Colombian populations. Am. J. Hum. Biol. 20, 584-591 (2008).
37. Chatterjee, K., Williamson, A.-L., Hoffman, M. & Dandara, C. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer. J. Med. Virol. 83, 630-636 (2011).
38. Guimaraes, V., Guimaraes, R., Brandao, L., Baldez da Silva, M.F.P.T., Milanese, M., Segat, L. et al. Association between MBL2 gene functional polymorphisms and highrisk human papillomavirus infection in Brazilian women. Hum. Immunol. 69, 273-278 (2008).
39. Ueda, M., Toji, E., Nunobiki, O., Sato, N., Izuma, S., Torii, K. et al. Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis. Hum. Cell 23, 119-125 (2010).
40. Martínez-Redondo, D., Marcuello, A., Casajú s, J. A., Ara, I., Dahmani, Y., Montoya, J. et al. Human mitochondrial haplogroup H: The highest VO2max consumer-Is it a paradox? Mitochondrion 10, 102-107 (2010).
41. Raj, K., Berguerand, S., Southern, S., Doorbar, J. & Beard, P. E1-E4 protein of human papillomavirus type 16 associates with mitochondria. J. Virol. 78, 7199-7207 (2004). (Pubitemid 38781558)
42. Shim, J. H., Kim, K. H., Cho, Y. S., Choi, H. S., Song, E. Y., Myung, P. K. et al. Protective effect of oxidative stress in HaCaT keratinocytes expressing E7 oncogene. Amino Acids 34, 135-141 (2008).
43. Solaini, G., Sgarbi, G. & Baracca, A. Oxidative phosphorylation in cancer cells. Biochim. Biophys. Acta 1807, 534-542 (2011).
44. Koshikawa, N., Hayashi, J.-I., Nakagawara, A. & Takenaga, K. Reactive oxygen speciesgenerating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1 alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J. Biol. Chem. 284, 33185-33194 (2009).
45. Ishikawa, K. & Hayashi, J.-I. A novel function of mtDNA: Its involvement in metastasis. Ann. N Y Acad. Sci. 1201, 40-43 (2010).
46. Achilli, A., Perego, U. A., Bravi, C. M., Coble, M. D., Kong, Q.-P., Woodward, S. R. et al. The phylogeny of the four Pan-American mtDNA haplogroups: Implications for evolutionary and disease studies. PLoS One 3, e1764 (2008).
47. Shutt, T. E. & Shadel, G. S. A compendium of human mitochondrial gene expression machinery with links to disease. Environ. Mol. Mutagen. 51, 360-379 (2010).
48. Chen, X. J. & Butow, R. A. The organization and inheritance of the mitochondrial genome. Nat. Rev. Genet. 6, 815-825 (2005).
49. Boulet, L., Karpati, G. & Shoubridge, E. A. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and raggedred fibers (MERRF). Am. J. Hum. Genet. 51, 1187-1200 (1992). (Pubitemid 23001078)
50. Pavon-Eternod, M., Gomes, S., Geslain, R., Dai, Q., Rosner, M. R. & Pan, T. tRNA overexpression in breast cancer and functional consequences. Nucleic Acids Res. 37, 7268-7280 (2009).
51. Swire, J., Judson, O. P. & Burt, A. Mitochondrial genetic codes evolve to match amino acid requirements of proteins. J. Mol. Evol. 60, 128-139 (2005). (Pubitemid 40310765)
52. Mei, Y., Yong, J., Liu, H., Shi, Y., Meinkoth, J., Dreyfuss, G. et al. tRNA binds to cytochrome c and inhibits caspase activation. Mol. Cell 37, 668-678 (2010).